When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.
We've helped hundreds of companies discover their next life-improving compound.
We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding adoptive cell therapy capabilities:
In 2019 Labcorp welcomed the preclinical pharmacology oncology provider, MI Bioresearch, into the Labcorp family. You can now access hundreds of cell line assays and tumor models, as well as thousands of potential oncology patients for clinical trials or explore an extensive library of oncology diagnostics.